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Karyotype analysis of Ewing family of tumours, which includes
Ewing’s sarcoma, primitive neuroectodermal tumours and Askin
tumours, revealed characteristic translocations t(11;22) or t(21;22)
(Whang-Peng et al, 1984; Sorensen et al, 1994), and such chromo-
somal rearrangement resulted in the expression of the aberrant
fusion products which may be responsible for malignancy
(Delattre et al, 1992; Rabbitts et al, 1994). Molecular analysis of
these translocations revealed that 5¢-region of EWS (from band
22q12) is fused to the 3¢-region of Fli-1 gene (from band 11q24) or
erg gene (from band 21q22). Functional characterization of the
EWS-Fli-1 and EWS-erg chimaeric proteins suggested that they
function as transcriptional activators (May et al, 1993; Ohno et al,
1993; Bailly et al, 1994). The extreme carboxyl terminal region of
Fli-1 and erg protein is responsible for sequence specific DNA
binding (Reddy et al, 1991; Rao et al, 1993). EWS protein was
shown to be an RNA binding protein (Ohno et al, 1994), and the
amino-terminal region of EWS protein was shown to function as a
regulatory domain or as a transactivator domain depending on the
target sequences used (May et al, 1993; Ohno et al, 1993; Bailly
et al, 1994). Recently, some of the target genes modulated by the
EWS-Fli-1 protein have been identified (Braun et al, 1995; May
et al, 1997). Ewing’s sarcoma cells transfected with antisense
EWS-fusion expression plasmids were severely impaired in
growth, colony formation, and tumorigenicity in nude mice
(Ouchida et al, 1995). Antisense EWS-Fli-1 oligodeoxynucleo-
tides against the fusion RNA were also shown to reduce the
growth of the tumour cells significantly both in vitro and in vivo
(Tanaka et al, 1997). Antisense DNA has been considered to
inhibit the expression of protein products of the transcripts through
several mechanisms (Haeuptle et al, 1986; Munroe, 1988; Walder
and Walder, 1988).
It has been known that signal-transducing phospholipases and
lipid-derived messengers may be involved in cell proliferation,
and differentiation (Rhee, 1994; Singer et al, 1997).
Phosphoinositide-specific phospholipase C (PI-PLC) generates
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG) from
phosphatidylinositol-4, 5 bisphosphate (PIP2). IP3 stimulates the
release of Ca2+ from intracellular stores and DG activates protein
kinase C (PKC) (Berridge and Irvine, 1984; Nishizuka, 1986).
PI-PLC isozymes comprise a family of ten distinct enzymes at
least (Rhee, 1994; Rhee and Bae, 1997; Singer et al, 1997). Two
major subclasses of the mammalian enzymes, PLCb and PLCg,
have been shown to be activated through G protein-linked recep-
tors such as bradykinin (BK) and tyrosine kinase-linked receptors
such as platelet-derived growth factor (PDGF) respectively.
In the present study, for the better understanding of the
EWS-Fli-1 function in terms of cellular signal transduction
mechanism, we have examined the phosphatidylinositol signalling
in Ewing’s sarcoma cells stably transfected with antisense
EWS-Fli-1 expression plasmid.
MATERIALS AND METHODS
Cell culture and cell labelling
Ewing’s sarcoma cell line (TC 135) kindly gifted from Dr Triche
(Univ. Southern California, CA, USA) were transfected with
pcDNA expression vector carrying antisense EWS-Fli-1 and with
empty pcDNA vector for control and were selected for G-418-
resistant permanent cell lines as described previously (Ouchida
et al, 1995). For the measurement of inositol phosphate, cells were
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labelled with [3H]inositol (1 mCi ml–1) in inositol-free minimum
Eagle’s medium containing 0.3% bovine serum albumin (BSA) for
36 h.
Western blot analysis
Ewing’s sarcoma cells (pcDNA-vector with or without antisense
EWS-Fli-1) were grown in 100-mm dishes to near confluency and
washed twice in Ca2+/Mg2+-free phosphate-buffered saline (PBS).
Cells were solubilized with ice-cold lysis buffer (1% Triton X-100,
0.1% sodium dodecyl sulphate (SDS), 0.5% sodium cholate, 10
mM EDTA, 10 mM EGTA, 50 mM sodium chloride (NaCl), 25 mM
HEPES, 1 mM phenylmethylsulphonyl fluoride, and 10 mg ml–1
leupeptin, pH 7.40). Insoluble materials were removed by
centrifugation at 14 000 g for 20 min at 4°C. Proteins
(100 mg) were separated by SDS polyacrylamide gel electro-
phoresis (SDS-PAGE) according to the method by Laemmli
(1970). Electrophoretic blotting onto nitrocellulose membrane was
carried out as the procedure of Towbin (1979). The nitrocellulose
membrane was incubated with antibodies against Fli-1, PLCb1,
b2, b3, b4, g1, g2, d1, d2, PKCa, b1, b2, g, d, e, z, Gqa (Santa
Cruz Biotechnology, Inc., CA, USA) and Gi2a (Kyowa Hako,
Kyoto, Japan) overnight. The quantitative determination of the
proteins were performed by a densitometer (Atto, Densitograph
series 1).
Measurement of inositol phosphates
The [3H]inositol-labelled cells were washed two times with
modified Krebs-Ringer buffer consisting of 125 mM NaCl, 5 mM
potassium chloride (KCl), 1.2 mM KH2PO4, 1.2 mM MgSO4,
2m M calcium chloride (CaCl2), 6 mM glucose, 0.1% BSA, 25 mM
Hepes (pH 7.4), and 20 mM LiCl. Experiments were conducted by
the adding agonists to the labelled cells, and the reaction was
terminated by the addition of 0.5 ml of 10% perchloric acid to
each well. Inositol phosphates were separated using Dowex
AG1-X8 anion exchange resin (200–400 mesh, formate form,
Bio-Rad Laboratories) as described elsewhere (Banno et al, 1994).
Protein was determined with the Bio-Rad protein assay kit using
BSA as standard.
RESULTS AND DISCUSSION
We have transfected Ewing’s sarcoma cell lines (TC135) with
pcDNA expression vector carrying antisense EWS-Fli-1 cDNA
and obtained ten G-418 resistant clones. These clones were
characterized for the expression of antisense transcripts of EWS-
Fli-1 by RT-PCR as we described before (Ouchida et al, 1995),
with specific primers for the cytomegalovirus promotor in pcDNA
and EWS, and selected three cell lines that highly expressed anti-
sense EWS-Fli-1 transcripts confirmed by Northern blotting with
RNA probe synthesized by in vitro transcription with EWS-Fli-1
expression plasmid (data not shown). In all of three cell lines,
morphological changes were observed, e.g. elliptic shape and
longer processes compared with the control small round cells.
Western blotting analyses were carried out in these cell lines.
These results revealed that there was a significant loss of expres-
sion of EWS-Fli-1 protein in Ewing’s sarcoma cells transfected
with antisense EWS-Fli-1 cDNA (Figure 1A). We have also
compared the growth of these cell lines with TC 135 cells trans-
fected with empty vector. The growth of Ewing’s sarcoma cells
expressing antisense EWS-Fli-1 was partially inhibited compared
to the parent Ewing’s sarcoma cells (Figure 1B).
Next we studied the production of inositol phosphates (IPs) in
these cells. As shown in Figure 2, in Ewing’s sarcoma cells trans-
fected with or without antisense EWS-Fli-1, IPs production was
stimulated by PDGF or BK. No significant difference in IPs
production was observed in both cell types stimulated by PDGF.
In contrast, IPs production induced by BK was considerably
suppressed in the antisense EWS-Fli-1-transfected cells. These
results suggest that the suppression of cell growth by transfecting
antisense EWS-Fli-1 may be at least in part due to impairment of
inositol lipid turnover mediated via G-protein coupled receptor
activation rather than via tyrosine phosphorylation.
To examine further the mechanisms of reduced IPs production,
immunoblotting was carried out in both cell types. Western blot
analysis with antibodies for PLC isozymes, b (1, 2, 3, 4), g (1, 2), d
(1, 2) revealed that PLCb1, b2, b3, g1, d1, and d2 were present in
both cells (Figures 3 and 4), but that PLC-b4 and g2 were not
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Figure 1 Expression of EWS-Fli-1 protein and growth of Ewing’s sarcoma
cells (TC 135) transfected with empty vector (C, control) or antisense EWS-
Fli-1 cDNA. (A) TC135 cells were lysed by sonication and the lysates (50 mg
protein) were subjected to electrophoresis on 10% SDS-polyacrylamide gel,
followed by immunostaining with antibody of Fli-1 protein. Lane 1, TC135
cells transfected with empty vector. Lanes 2, 3 and 4, TC135 cells
transfected with anti EWS-Fli-1 cDNA (A1: cell line no. 1, A2: cell line no. 2,
A3: cell line no. 3). (B) TC135 cells transfected with empty vector (control: l l)
or antisense EWS-Fli-1 (cell lines no. 1: n n, no. 2: l and no. 3: n) were
plated at a concentration of 2 ´ 105 cells in 60 mm dishes, and incubated for
the indicated times as described in Materials and methods. Cell numbers
counted one day after plating were taken as zero time. Points represent as
mean ± s.d. from duplicates determinations of two different experiments18 T Dohjima et al
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detectable (data not shown). No apparent di fferences were
observed in PLC -b1, g1, d1, an d d2 (Figure 4A). In contrast, to be
of great interest, PLC -b2 an d b3 were markedly down-regulated in
the antisense-transfected cells (Figure 3) compared with the
control cells. The quantitative determination of PLC isozymes
showed that PL Cb2 and PL Cb3 in the antisense-transfected cells
were reduced by 73% and 38% respectivel y.
PLC-bs are known to be activated by two G-protein families,
one is Gi/o which is inhibited by pertussis toxins (PTX), and the
other is Gq which is resistant to PTX. PL Cb1 and PL Cb3 are
activated by a subunits of Gq, whereas PLC -b2 is activated mainly
by basubunits of Gi/o (Rhee, 1994; Rhee and Bae, 1997; Singer
et al, 1997). No significant di fferences in expression of G qaand
Gi2awere observed between both types of cells (Figure 4B).
These results lead us to consider that suppression of inositol
phosphates production in EWS-Fli-1 antisense-transfected cells
may be due to the decrease of PL Cb2 an d b3.
In addition, PKC isozymes were also examined, PKC isozymes
were expressed in various levels in Ewing ’s sarcoma cells.
Western blot analysis showed quantitative di fferences in PK Ca,
b1 an d b2 between both cells (Figure 4C). The levels of PK Ca, b1
and b2 were reduced by 44%, 57% and 30% in the transfected
cells respectivel y, as compared with the control cells.
These results indicate that suppression of proliferation caused
by transfecting the antisense EWS-Fli-1 could be at least in part
due to impairment of the signalling pathway mediated by PL Cb2
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Figure 2Inositol phosphates production of Ewing’s sarcoma cells (TC135)
transfected with or without antisense EWS-Fli-1. TC135 cells transfected with
pcDNA-vector (n: control) or with antisense EWS-Fli-1 (n: antisense, A1: cell
line no. 1, A2: cell line no. 2, A3: cell line no. 3) were labelled with
[3H]myoinositol (1mCi ml–1) for 24h. The labelled cells were stimulated with
platelet-derived growth factor (PDGF, 10ng ml–1) for 10min (A), or bradykinin
(1mM) for 1min (B) in the presence of 25mMLiCl. [3H]Inositol phosphates
were eluted through anion exchange column (AG1 ´8) by eluting with
ammonium formate. The results were represented as means ±s.d. from
triplicate determinations of two separate experiments
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Figure 3Immunoblots of PLCb2 and PLCb3 expression in Ewing’s
sarcoma cells (TC135) transfected with or without antisense EWS-Fli-1.
The cell lysates (100mg proteins) were subjected to electrophoresis on 8%
polyacrylamide gel and Western blot analysis was performed with
anti-PLCb2 and PLCb3 antibodies. The molecular masses of the detected
protein bands; PLCb2, 140kDa; PLCb3, 155kDa. Lane 1, TC135 cells
transfected with empty vector. Lanes 2, 3 and 4, TC135 cells transfected
with anti EWS-Fli-1 cDNA (A1: cell line no. 1, A2: cell line no. 2, A3:
cell line no. 3). Data are representative of three experiments
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Figure 4Immunoblots of PLC isozymes, G proteins and PKC isozymes
expression in Ewing’s sarcoma cells transfected with or without antisense
EWS-Fli-1. The cell lysates (100mg proteins) were subjected to
electrophoresis on 13% (for G proteins) and 8% (for PLC and PKC isozymes)
polyacrylamide gels and western blot analysis was performed with antibodies
against PLC and PKC isozymes and G proteins. The molecular masses of
the detected protein bands; PLC-b1, 150kDa; PLCg1, 145kDa; PLCd1,
85kDa; PLCd2, 85kDa. Gqa, 43kDa; Gi2a, 42kDa; PKCa, 81kDa; PKCb1,
82kDa; PKCb2, 80kDa. (C: control cell, transfected with pcDNA-vector);
(A: antisense cell, transfected antisense EWS-Fli-1/pcDNA). Data are
representative of three experimentsDecrease of PLCb by antisense EWS-Fli-1 transfection 19
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and PLCb3 activation and also by the subsequent activation of
PKCa, b1, b2. Numerous studies have shown that PLCg which is
activated by tyrosine phosphorylation is involved in cell growth
and carcinogenesis (Ji et al, 1997). On the other hand, it has been
demonstrated that PLCg activation is not essential for FGF
receptor-mediating cell growth (Mohammadi, 1992; Peters et al,
1992). Furthermore, recent study has indicated essential role of
PLCg1 in mammalian growth (Ji et al, 1997). There have been
some reports describing reduction or loss of expression of PLCb
isozymes in human diseases, e.g. loss of PLCb3 gene expression
in MEN1 disease (multiple endocrine neoplasia type 1) (Weber
et al, 1994) and decreased PLCb2 expression in abnormal platelet
aggregation (Lee et al, 1996). Furthermore, recent study has
demonstrated that expression of catalytically inactive PLCb
inhibits growth of small-cell lung cancer, indicating that signalling
through Gq and PLCb is a dominant pathway involved in the
transformed growth of cancer cells (Beekman et al, 1998). In our
study, we have shown that in Ewing’s sarcoma cells expressing the
antisense EWS-Fli-1 transcripts, the levels of PLCb2 and PLCb3
were much more decreased than the level of PLCg1, suggesting
that PLCb2 and PLCb3 may play an important role in cell
proliferation in Ewing’s sarcoma cells.
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